bf/NYSE:BSX_icon.jpeg

NYSE:BSX

Boston Scientific Corporation

  • Stock

USD

Last Close

72.03

03/05 20:00

Market Cap

89.55B

Beta: 0.80

Volume Today

7.21M

Avg: 8.81M

PE Ratio

77.02

PFCF: 58.40

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-121M
-
-119M
1.65%
-239M
100.84%
347M
245.19%
104M
70.03%
1.67B
1,506.73%
4.70B
181.27%
-82M
101.74%
1.04B
1,369.51%
698M
32.95%
1.59B
128.08%
depreciation and amortization
689M
-
725M
5.22%
769M
6.07%
815M
5.98%
844M
3.56%
894M
5.92%
1.01B
13.09%
1.12B
11.08%
1.09B
2.67%
1.14B
3.93%
1.20B
5.28%
deferred income tax
-223M
-
-397M
78.03%
-532M
34.01%
-305M
42.67%
245M
180.33%
-87M
135.51%
-4.30B
4,843.68%
-82M
98.09%
-124M
51.22%
-63M
49.19%
-1M
98.41%
stock based compensation
105M
-
103M
1.90%
107M
3.88%
116M
8.41%
127M
9.48%
140M
10.24%
157M
12.14%
170M
8.28%
194M
14.12%
220M
13.40%
233M
5.91%
change in working capital
155M
-
962M
520.65%
280M
70.89%
-4M
101.43%
66M
1,750%
-2.16B
3,372.73%
-282M
86.94%
42M
114.89%
-351M
935.71%
-1.00B
186.32%
-770M
23.38%
accounts receivables
-101M
-
53M
152.48%
-17M
132.08%
-216M
1,170.59%
-30M
86.11%
-110M
266.67%
-130M
18.18%
335M
357.69%
-279M
183.28%
-220M
21.15%
-238M
8.18%
inventory
-7M
-
-81M
1,057.14%
3M
103.70%
40M
1,233.33%
-107M
367.50%
-83M
22.43%
-290M
249.40%
-65M
77.59%
-346M
432.31%
-321M
7.23%
-660M
105.61%
accounts payables
-37M
-
620M
1,775.68%
-20M
103.23%
553M
2,865%
195M
64.74%
-710M
464.10%
111M
115.63%
88M
20.72%
408M
363.64%
-255M
162.50%
118M
146.27%
other working capital
300M
-
370M
23.33%
314M
15.14%
-381M
221.34%
8M
102.10%
-1.26B
15,812.50%
27M
102.15%
-316M
1,270.37%
-134M
57.59%
-209M
55.97%
780M
473.21%
other non cash items
477M
-
-5M
101.05%
215M
4,400%
3M
98.60%
40M
1,233.33%
-148M
470%
551M
472.30%
337M
38.84%
17M
94.96%
540M
3,076.47%
253M
53.15%
net cash provided by operating activities
1.08B
-
1.27B
17.28%
600M
52.72%
972M
62%
1.43B
46.71%
310M
78.26%
1.84B
492.26%
1.51B
17.86%
1.87B
24.01%
1.53B
18.40%
2.50B
64.02%
investments in property plant and equipment
-245M
-
-259M
5.71%
-247M
4.63%
-376M
52.23%
-319M
15.16%
-316M
0.94%
-461M
45.89%
-376M
18.44%
-554M
47.34%
-612M
10.47%
-800M
30.72%
acquisitions net
-244M
-
-474M
94.26%
-1.73B
265.82%
-408M
76.47%
-560M
37.25%
-1.45B
158.57%
-4.29B
196.41%
12M
100.28%
-1.43B
12,033.33%
-1.54B
7.33%
-1.81B
17.83%
purchases of investments
-44M
-
-26M
40.91%
-266M
923.08%
-132M
50.38%
-131M
0.76%
-172M
31.30%
-348M
102.33%
-146M
58.05%
96M
165.75%
-24M
125%
-55M
129.17%
sales maturities of investments
5M
-
14M
180%
61M
335.71%
131M
-
14M
89.31%
59M
321.43%
12M
79.66%
294M
2,350%
56M
80.95%
2M
96.43%
other investing activites
53M
-
29M
-
-131M
551.72%
1M
100.76%
1M
0%
87M
8,600%
-1M
101.15%
106M
10,700%
90M
15.09%
net cash used for investing activites
-475M
-
-745M
56.84%
-2.19B
193.42%
-887M
59.42%
-1.01B
13.87%
-1.92B
90.20%
-5.04B
162.42%
-411M
91.85%
-1.60B
288.56%
-2.01B
25.92%
-2.57B
28.00%
debt repayment
-1.79B
-
-810M
54.75%
-1.72B
111.73%
-820M
52.19%
-3.22B
292.20%
-1.17B
63.59%
-4.56B
289.41%
-6.84B
50.07%
-110M
98.39%
-3.44B
3,022.73%
-4M
99.88%
common stock issued
74M
-
60M
18.92%
114M
90%
111M
2.63%
85M
23.42%
101M
18.82%
123M
21.78%
975M
692.68%
110M
88.72%
136M
23.64%
-56M
141.18%
common stock repurchased
-500M
-
-125M
75%
-535M
-
110M
120.56%
136M
23.64%
182M
33.82%
dividends paid
-1.78B
-
-759M
57.36%
-28M
-
-55M
96.43%
-55M
0%
-28M
49.09%
other financing activites
3.40B
-
1.48B
56.35%
2.92B
96.97%
503M
82.79%
3.24B
544.33%
2.50B
22.80%
7.41B
196.16%
6.72B
9.26%
-150M
102.23%
2.67B
1,880%
-89M
103.33%
net cash used provided by financing activities
-596M
-
-150M
74.83%
1.32B
981.33%
-206M
115.58%
110M
153.40%
1.43B
1,201.82%
2.97B
107.61%
293M
90.14%
-95M
132.42%
-548M
476.84%
5M
100.91%
effect of forex changes on cash
-1M
-
-4M
300%
-4M
0%
-2M
50%
4M
300%
-8M
300%
10M
225%
-2M
120%
-6M
200%
-9M
50%
-4M
55.56%
net change in cash
10M
-
370M
3,600%
-268M
172.43%
-123M
54.10%
530M
530.89%
-188M
135.47%
-222M
18.09%
1.39B
725.23%
173M
87.54%
-1.04B
702.31%
-71M
93.19%
cash at beginning of period
207M
-
217M
4.83%
587M
170.51%
319M
45.66%
487M
52.66%
1.02B
108.83%
829M
18.49%
607M
26.78%
2.00B
228.67%
2.17B
8.67%
1.13B
48.06%
cash at end of period
217M
-
587M
170.51%
319M
45.66%
196M
38.56%
1.02B
418.88%
829M
18.49%
607M
26.78%
2.00B
228.67%
2.17B
8.67%
1.13B
48.06%
1.05B
6.31%
operating cash flow
1.08B
-
1.27B
17.28%
600M
52.72%
972M
62%
1.43B
46.71%
310M
78.26%
1.84B
492.26%
1.51B
17.86%
1.87B
24.01%
1.53B
18.40%
2.50B
64.02%
capital expenditure
-245M
-
-259M
5.71%
-247M
4.63%
-376M
52.23%
-319M
15.16%
-316M
0.94%
-461M
45.89%
-376M
18.44%
-554M
47.34%
-612M
10.47%
-800M
30.72%
free cash flow
837M
-
1.01B
20.67%
353M
65.05%
596M
68.84%
1.11B
85.74%
-6M
100.54%
1.38B
23,016.67%
1.13B
17.67%
1.32B
16.25%
914M
30.55%
1.70B
86.32%

All numbers in USD (except ratios and percentages)